Elevated transcription factor specificity protein 1 in autistic brains alters the expression of autism candidate genes

Biological Psychiatry

Volumn 71, Issue 5, 2012, Pages 410-418

  Thanseem, Ismail ^a   Anitha, Ayyappan ^a   Nakamura, Kazuhiko ^a   Suda, Shiro ^a   Iwata, Keiko ^a   Matsuzaki, Hideo ^a   Ohtsubo, Masafumi ^a   Ueki, Takatoshi ^a   Katayama, Taiichi ^b   Iwata, Yasuhide ^a   Suzuki, Katsuaki ^a   Minoshima, Shinsei ^a   Mori, Norio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Autism; heterogeneity; postmortem brain; RNAi; Sp1; transcription factor

Indexed keywords

MITHRAMYCIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; AUTISM; CINGULATE GYRUS; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; GENE SILENCING; HUMAN; MOTOR CORTEX; NERVE CELL; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RNA INTERFERENCE; THALAMUS;

ADOLESCENT; ADULT; AUTISTIC DISORDER; BRAIN; CELLS, CULTURED; CHILD; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; PLICAMYCIN; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR;

EID: 84858752028     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.09.020     Document Type: Article

References (68)

1. O. Bozdagi, T. Sakurai, D. Papapetrou, X. Wang, D.L. Dickstein, N. Takahashi Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication Mol Autism 1 2010 15
2. A. Guilmatre, C. Dubourg, A.L. Mosca, S. Legallic, A. Goldenberg, V. Drouin-Garraud Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation Arch Gen Psychiatry 66 2009 947 956
3. T. Munesue, S. Yokoyama, K. Nakamura, A. Anitha, K. Yamada, K. Hayashi Two genetic variants of CD38 in subjects with autism spectrum disorder and controls Neurosci Res 67 2010 181 191
4. J. Park, M. Willmott, G. Vetuz, C. Toye, A. Kirley, Z. Hawi Evidence that genetic variation in the oxytocin receptor (OXTR) gene influences social cognition in ADHD Prog Neuropsychopharmacol Biol Psychiatry 34 2010 697 702
5. J.A. Rosenfeld, B.C. Ballif, B.S. Torchia, T. Sahoo, J.B. Ravnan, R. Schultz Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders Genet Med 12 2010 694 702
6. A.A. Scott-Van Zeeland, B.S. Abrahams, A.I. Alvarez-Retuerto, L.I. Sonnenblick, J.D. Rudie, D. Ghahremani Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2 Sci Transl Med 2 2010 56ra80
7. G.H. Perdew, J.P. Vanden Heuvel, J.M. Peters Regulation of Gene Expression: Molecular Mechanisms 2006 Humana Press Totowa, New Jersey
8. D. Ben-Shachar, R. Karry Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2 PLoS One 2 2007 e817
9. P. Bouwman, S. Philipsen Regulation of the activity of Sp1-related transcription factors Mol Cell Endocrinol 195 2002 27 38 (Pubitemid 35287159)
10. I. Wierstra Sp1: Emerging rolesbeyond constitutive activation of TATA-less housekeeping genes Biochem Biophys Res Commun 372 2008 1 13
11. C. Banchio, L.M. Schang, D.E. Vance Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP: Phosphocholine cytidylyltransferase alpha regulation during the S phase of the cell cycle J Biol Chem 279 2004 40220 40226 (Pubitemid 39258298)
12. J.D. Saffer, S.P. Jackson, S.J. Thurston SV40 stimulates expression of the transacting factor Sp1 at the mRNA level Genes Dev 4 1990 659 666
13. G. Suske The Sp-family of transcription factors Gene 238 1999 291 300 (Pubitemid 29446168)
14. S. Vaulont, M. Vasseur-Cognet, A. Kahn Glucose regulation of gene transcription J Biol Chem 275 2000 31555 31558
15. M. Marin, A. Karis, P. Visser, F. Grosveld, S. Philipsen Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation Cell 89 1997 619 628 (Pubitemid 27511772)
16. J.D. Saffer, S.P. Jackson, M.B. Annarella Developmental expression of Sp1 in the mouse Mol Cell Biol 11 1991 2189 2199 (Pubitemid 21895591)
17. B.A. Citron, J.S. Dennis, R.S. Zeitlin, V. Echeverria Transcription factor Sp1 dysregulation in Alzheimer's disease J Neurosci Res 86 2008 2499 2504
18. S. Cawley, S. Bekiranov, H.H. Ng, P. Kapranov, E.A. Sekinger, D. Kampa Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs Cell 116 2004 499 509 (Pubitemid 38264428)
19. B.S. Abrahams, D.H. Geschwind Advances in autism genetics: On the threshold of a new neurobiology Nat Rev Genet 9 2008 341 355 (Pubitemid 351556064)
20. S.W. Blume, R.C. Snyder, R. Ray, S. Thomas, C.A. Koller, D.M. Miller Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo J Clin Invest 88 1991 1613 1621
21. Z. Qiu, F. Norflus, B. Singh, M.K. Swindell, R. Buzescu, M. Bejarano Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective J Biol Chem 281 2006 16672 16680
22. D.L. Vargas, C. Nascimbene, C. Krishnan, A.W. Zimmerman, C.A. Pardo Neuroglial activation and neuroinflammation in the brain of patients with autism Ann Neurol 57 2005 67 81 (Pubitemid 40053317)
23. Y.T. Oh, J.Y. Lee, H. Yoon, E.H. Lee, H.H. Baik, S.S. Kim Lipopolysaccharide induces hypoxia-inducible factor-1 alpha mRNA expression and activation via NADPH oxidase and Sp1-dependent pathway in BV2 murine microglial cells Neurosci Lett 431 2008 155 160
24. A. Chauhan, V. Chauhan, W.T. Brown, I. Cohen Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrinthe antioxidant proteins Life Sci 75 2004 2539 2549 (Pubitemid 39195260)
25. W.R. McGinnis Oxidative stress in autism Altern Ther Health Med 10 2004 22 36 quiz 37, 92
26. H. Ryu, J. Lee, K. Zaman, J. Kubilis, R.J. Ferrante, B.D. Ross Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons J Neurosci 23 2003 3597 3606 (Pubitemid 36958467)
27. D. Trisciuoglio, A. Iervolino, A. Candiloro, G. Fibbi, M. Fanciulli, U. Zangemeister-Wittke bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: Involvement of ERK1/ERK2 activity J Biol Chem 279 2004 6737 6745 (Pubitemid 38248814)
28. M.M. Haznedar, M.S. Buchsbaum, M. Metzger, A. Solimando, J. Spiegel-Cohen, E. Hollander Anterior cingulate gyrus volume and glucose metabolism in autistic disorder Am J Psychiatry 154 1997 1047 1050 (Pubitemid 27328817)
29. K. Nakamura, Y. Sekine, Y. Ouchi, M. Tsujii, E. Yoshikawa, M. Futatsubashi Brain serotonin and dopamine transporter bindings in adults with high-functioning autism Arch Gen Psychiatry 67 2010 59 68
30. T. Ohnishi, H. Matsuda, T. Hashimoto, T. Kunihiro, M. Nishikawa, T. Uema Abnormal regional cerebral blood flow in childhood autism Brain 123 2000 1838 1844 (Pubitemid 30664286)
31. D.E. Welchew, C. Ashwin, K. Berkouk, R. Salvador, J. Suckling, S. Baron-Cohen Functional disconnectivity of the medial temporal lobe in Asperger's syndrome Biol Psychiatry 57 2005 991 998 (Pubitemid 40613034)
32. O. Devinsky, M.J. Morrell, B.A. Vogt Contributions of anterior cingulate cortex to behaviour Brain 118 1995 279 306
33. R.D. Lane, E.M. Reiman, B. Axelrod, L.S. Yun, A. Holmes, G.E. Schwartz Neural correlates of levels of emotional awareness Evidence of an interaction between emotion and attention in the anterior cingulate cortex J Cogn Neurosci 10 1998 525 535 (Pubitemid 28377239)
34. B.A. Vogt, D.M. Finch, C.R. Olson Functional heterogeneity in cingulate cortex: The anterior executive and posterior evaluative regions Cereb Cortex 2 1992 435 443
35. A.W. Dunah, H. Jeong, A. Griffin, Y.M. Kim, D.G. Standaert, S.M. Hersch Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease Science 296 2002 2238 2243 (Pubitemid 34680312)
36. S.H. Fatemi, T.D. Folsom Dysregulation of fragile × mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: A postmortem brain study Mol Autism 2 2011 6
37. S.G. Gregory, J.J. Connelly, A.J. Towers, J. Johnson, D. Biscocho, C.A. Markunas Genomic and epigenetic evidence for oxytocin receptor deficiency in autism BMC Med 7 2009 62
38. T.M. DeLorey GABRB3 gene deficient mice: A potential model of autism spectrum disorder Int Rev Neurobiol 71 2005 359 382
39. T.M. DeLorey, P. Sahbaie, E. Hashemi, G.E. Homanics, J.D. Clark Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: A potential model of autism spectrum disorder Behav Brain Res 187 2008 207 220
40. S.H. Fatemi, A.V. Snow, J.M. Stary, M. Araghi-Niknam, T.J. Reutiman, S. Lee Reelin signaling is impaired in autism Biol Psychiatry 57 2005 777 787 (Pubitemid 40487922)
41. D.G. Murphy, E. Daly, N. Schmitz, F. Toal, K. Murphy, S. Curran Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: An in vivo SPECT study Am J Psychiatry 163 2006 934 936 (Pubitemid 44464547)
42. A. Levy, A. Bercovich-Kinori, A.G. Alexandrovich, J. Tsenter, V. Trembovler, F.E. Lund CD38 facilitates recovery from traumatic brain injury J Neurotrauma 26 2009 1521 1533
43. L. Mayo, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, M.J. Moutin, F.E. Lund Dual role of CD38 in microglial activation and activation-induced cell death J Immunol 181 2008 92 103
44. L. Mayo, R. Stein Characterization of LPS and interferon-gamma triggered activation-induced cell death in N9 and primary microglial cells: Induction of the mitochondrial gateway by nitric oxide Cell Death Differ 14 2007 183 186 (Pubitemid 44911905)
45. S. Partida-Sanchez, P. Iribarren, M.E. Moreno-Garcia, J.L. Gao, P.M. Murphy, N. Oppenheimer Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose J Immunol 172 2004 1896 1906 (Pubitemid 38116840)
46. L.A. Weiss, G. Kosova, R.J. Delahanty, L. Jiang, E.H. Cook, C. Ober Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility Eur J Hum Genet 14 2006 923 931 (Pubitemid 44111630)
47. A.M. Coutinho, I. Sousa, M. Martins, C. Correia, T. Morgadinho, C. Bento Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels Hum Genet 121 2007 243 256 (Pubitemid 46404458)
48. G.R. DeLong Autism: New data suggest a new hypothesis Neurology 52 1999 911 916
49. R.P. Nagarajan, A.R. Hogart, Y. Gwye, M.R. Martin, J.M. LaSalle Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation Epigenetics 1 2006 e1 e11
50. M. Chahrour, S.Y. Jung, C. Shaw, X. Zhou, S.T. Wong, J. Qin MeCP2, a key contributor to neurological disease, activates and represses transcription Science 320 2008 1224 1229 (Pubitemid 351929512)
51. M.L. Gonzales, J.M. LaSalle The role of MeCP2 in brain development and neurodevelopmental disorders Curr Psychiatry Rep 12 2010 127 134
52. R.C. Samaco, R.P. Nagarajan, D. Braunschweig, J.M. LaSalle Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders Hum Mol Genet 13 2004 629 639 (Pubitemid 38379852)
53. M. Brandeis, D. Frank, I. Keshet, Z. Siegfried, M. Mendelsohn, A. Nemes Sp1 elements protect a CpG island from de novo methylation Nature 371 1994 435 438 (Pubitemid 24302561)
54. K. Nishimori, Y. Takayanagi, M. Yoshida, Y. Kasahara, L.J. Young, M. Kawamata New aspects of oxytocin receptor function revealed by knockout mice: Sociosexual behaviour and control of energy balance Prog Brain Res 170 2008 79 90 (Pubitemid 352010223)
55. M.G. Butler, M.J. Dasouki, X.P. Zhou, Z. Talebizadeh, M. Brown, T.N. Takahashi Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations J Med Genet 42 2005 318 321 (Pubitemid 40523954)
56. G.E. Herman, E. Butter, B. Enrile, M. Pastore, T.W. Prior, A. Sommer Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly Am J Med Genet A 143 2007 589 593 (Pubitemid 46348901)
57. S. Musatov, J. Roberts, A.I. Brooks, J. Pena, S. Betchen, D.W. Pfaff Inhibition of neuronal phenotype by PTEN in PC12 cells Proc Natl Acad Sci U S A 101 2004 3627 3631 (Pubitemid 38338245)
58. I. Wierstra Sp1: Emerging roles- Beyond constitutive activation of TATA-less housekeeping genes Biochem Biophys Res Commun 372 2008 1 13
59. Y. Chen, M. Kundakovic, R.C. Agis-Balboa, G. Pinna, D.R. Grayson Induction of the reelin promoter by retinoic acid is mediated by Sp1 J Neurochem 103 2007 650 665 (Pubitemid 47498032)
60. S.L. Eastwood, P.J. Harrison Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: Towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis Mol Psychiatry 8 2003 769 821731
61. S.L. Eastwood, P.J. Harrison Cellular basis of reduced cortical reelin expression in schizophrenia Am J Psychiatry 163 2006 540 542 (Pubitemid 44469402)
62. S.H. Fatemi, J.A. Earle, T. McMenomy Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression Mol Psychiatry 5 2000 654 663 571
63. A. Guidotti, J. Auta, J.M. Davis, V. Di-Giorgi-Gerevini, Y. Dwivedi, D.R. Grayson Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study Arch Gen Psychiatry 57 2000 1061 1069
64. H.M. Abdolmaleky, K.H. Cheng, A. Russo, C.L. Smith, S.V. Faraone, M. Wilcox Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report Am J Med Genet B Neuropsychiatr Genet 134B 2005 60 66 (Pubitemid 40411111)
65. N. Sato, N. Fukushima, R. Chang, H. Matsubayashi, M. Goggins Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers Gastroenterology 130 2006 548 565 (Pubitemid 43202051)
66. T. Stein, E. Cosimo, X. Yu, P.R. Smith, R. Simon, L. Cottrell Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis Am J Pathol 177 2010 2323 2333
67. R.J. Ferrante, H. Ryu, J.K. Kubilus, S. D'Mello, K.L. Sugars, J. Lee Chemotherapy for the brain: The antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease J Neurosci 24 2004 10335 10342 (Pubitemid 39552617)
68. C.M. Monoranu, M. Apfelbacher, E. Grunblatt, B. Puppe, I. Alafuzoff, I. Ferrer pH measurement as quality control on human post mortem brain tissue: A study of the BrainNet Europe consortium Neuropathol Appl Neurobiol 35 2009 329 337